Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Apr 7, 2019; 25(13): 1618-1627
Published online Apr 7, 2019. doi: 10.3748/wjg.v25.i13.1618
Table 1 Univariate analysis of factors associated with argon plasma coagulation treatment failure for hemorrhagic chronic radiation proctitis.
VariableNo. of failure/total patientsP-value
Distribution of telangiectasias
Distal rectum (within 10 cm from anal verge)7/310.1361
Entire rectum +/− sigmoid (more than 10 cm from anal verge)7/14
Surface area covered by telangiectasias
Less than 50%2/190.0112
More than 50%12/26
Presence of fresh blood
No3/160.3201
Yes11/29
Ulceration
< 1 cm26/330.0061
> 1 cm28/12
Gender
Female14/400.3053
Male0/5
Hypertensive
No11/390.3563
Yes3/6
Diabetic
No11/400.1663
Yes3/5
Abdominal surgery
No11/330.8651
Yes3/12
Acute radiation injury
No14/390.1563
Yes0/6
Requiring blood transfusions
No7/300.2101
Yes7/15
Number of APC
111/330.8651
≥ 23/12
Age, yr
< 608/220.4572
≥ 606/23
BMI at the first treatment of APC, kg/m2
< 217/210.7632
≥ 217/24
Time from the end of radiotherapy to bleeding, mo
< 86/170.6372
≥ 88/28
Time from the end of radiotherapy to the first time of APC, mo
< 148/230.5862
≥ 146/22
Table 2 Univariate analysis of factors associated with argon plasma coagulation treatment complications for hemorrhagic chronic radiation proctitis
VariableNo. of complication/total patientsP-value
Distribution of telangiectasias
Distal rectum (within 10 cm from anal verge)4/311.0002
Entire rectum +/− sigmoid (more than 10 cm from anal verge)2/14
Surface area covered by telangiectasias
Less than 50%2/191.0002
More than 50%4/26
Presence of fresh blood
No1/160.3992
Yes5/29
Ulceration
< 1 cm22/330.0352
> 1 cm24/12
Gender
Female5/400.5292
Male1/5
Hypertensive
No4/390.3671
Yes2/6
Diabetic
No4/400.1252
Yes2/5
Abdominal surgery
No6/330.1712
Yes0/12
Acute radiation injury
No6/390.6991
Yes0/6
Requiring blood transfusions
No3/300.3842
Yes3/15
Number of APC
15/331.0002
≥ 21/12
Age, yr
< 601/220.1872
≥ 605/23
BMI at the first treatment of APC, kg/m2
< 213/211.0002
≥ 213/24
Time from the end of radiotherapy to bleeding, mo
< 82/171.0002
≥ 84/28
Time from the end of radiotherapy to the first time of APC, mo
< 144/230.6652
≥ 142/22